Literature DB >> 22534003

Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence.

Ryan Schwarz1, Alexei Zelenev, R Douglas Bruce, Frederick L Altice.   

Abstract

Drug users are marginalized from typical primary care, often resulting in emergency department (ED) usage and hospitalization due to late-stage disease. Though data suggest methadone decreases such fragmented healthcare utilization (HCU), the impact of buprenorphine maintenance treatment (BMT) on HCU is unknown. Chart review was conducted on opioid dependent patients seeking BMT, comparing individuals (n=59) who left BMT≤7days with those retained on BMT (n=150), for ED use and hospitalization. Using negative binomial regressions, including comparison of time before BMT induction, ED utilization and hospitalization were assessed. Overall, ED utilization was 0.93 events per person year and was significantly reduced by BMT, with increasing time (retention) on BMT. BMT had no significant effect on hospitalizations or average length of stay.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22534003      PMCID: PMC3419304          DOI: 10.1016/j.jsat.2012.03.008

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  41 in total

1.  Parity and the medicalization of addiction treatment.

Authors:  Ken Roy; Michael Miller
Journal:  J Psychoactive Drugs       Date:  2010-06

2.  Public managed care and service access in outpatient substance abuse treatment units.

Authors:  Emmeline Chuang; Rebecca Wells; Jeffrey A Alexander
Journal:  J Behav Health Serv Res       Date:  2011-10       Impact factor: 1.505

3.  The impact of screening, brief intervention and referral for treatment in emergency department patients' alcohol use: a 3-, 6- and 12-month follow-up.

Authors: 
Journal:  Alcohol Alcohol       Date:  2010-09-27       Impact factor: 2.826

4.  Service use and barriers to care among heroin users: results from a national survey.

Authors:  Orion Mowbray; Brian E Perron; Amy S B Bohnert; Amy R Krentzman; Michael G Vaughn
Journal:  Am J Drug Alcohol Abuse       Date:  2010-08-02       Impact factor: 3.829

5.  HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.

Authors:  Frederick L Altice; R Douglas Bruce; Gregory M Lucas; Paula J Lum; P Todd Korthuis; Timothy P Flanigan; Chinazo O Cunningham; Lynn E Sullivan; Pamela Vergara-Rodriguez; David A Fiellin; Adan Cajina; Michael Botsko; Vijay Nandi; Marc N Gourevitch; Ruth Finkelstein
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

Review 6.  Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.

Authors:  Frederick L Altice; Adeeba Kamarulzaman; Vincent V Soriano; Mauro Schechter; Gerald H Friedland
Journal:  Lancet       Date:  2010-07-31       Impact factor: 79.321

7.  Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience.

Authors:  Daniel P Alford; Colleen T LaBelle; Natalie Kretsch; Alexis Bergeron; Michael Winter; Michael Botticelli; Jeffrey H Samet
Journal:  Arch Intern Med       Date:  2011-03-14

8.  Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: policy implications for tuberculosis screening.

Authors:  Ryan K Schwarz; R Douglas Bruce; Samuel A Ball; Maua Herme; Frederick L Altice
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

9.  Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings.

Authors:  R Douglas Bruce
Journal:  Int J Drug Policy       Date:  2010-03

10.  Multi-centre observational study of buprenorphine use in 32 Italian drug addiction centres.

Authors:  C Leonardi; N Hanna; P Laurenzi; R Fagetti
Journal:  Drug Alcohol Depend       Date:  2007-12-26       Impact factor: 4.492

View more
  28 in total

1.  Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine.

Authors:  Chethan Bachireddy; Michael C Soule; Jacob M Izenberg; Sergey Dvoryak; Konstantin Dumchev; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2013-09-27       Impact factor: 4.492

2.  Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System.

Authors:  Cynthia I Campbell; Sujaya Parthasarathy; Kelly C Young-Wolff; Derek D Satre
Journal:  J Psychoactive Drugs       Date:  2017-04-20

3.  Accessibility and utilization patterns of a mobile medical clinic among vulnerable populations.

Authors:  Britton A Gibson; Debarchana Ghosh; Jamie P Morano; Frederick L Altice
Journal:  Health Place       Date:  2014-05-21       Impact factor: 4.078

4.  Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia.

Authors:  Nicola R Jones; Marian Shanahan; Timothy Dobbins; Louisa Degenhardt; Mark Montebello; Natasa Gisev; Sarah Larney
Journal:  Drug Alcohol Rev       Date:  2019-09

5.  Emergency department use among HIV-infected released jail detainees.

Authors:  Andrew T Boyd; Dahye L Song; Jaimie P Meyer; Frederick L Altice
Journal:  J Urban Health       Date:  2015-02       Impact factor: 3.671

6.  Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers.

Authors:  Marwan S Haddad; Alexei Zelenev; Frederick L Altice
Journal:  J Urban Health       Date:  2015-02       Impact factor: 3.671

7.  Predictors of early dropout in outpatient buprenorphine/naloxone treatment.

Authors:  David E Marcovitz; R Kathryn McHugh; Julie Volpe; Victoria Votaw; Hilary S Connery
Journal:  Am J Addict       Date:  2016-07-21

8.  Integrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes.

Authors:  Marwan S Haddad; Alexei Zelenev; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2013-01-17       Impact factor: 4.492

9.  Patient perspectives of an integrated program of medical care and substance use treatment.

Authors:  Mari-Lynn Drainoni; Caitlin Farrell; Amy Sorensen-Alawad; Joseph N Palmisano; Christine Chaisson; Alexander Y Walley
Journal:  AIDS Patient Care STDS       Date:  2014-01-15       Impact factor: 5.078

Review 10.  Buprenorphine Prescribing: To Expand or Not to Expand.

Authors:  Xiaofan Li; Daryl Shorter; Thomas R Kosten
Journal:  J Psychiatr Pract       Date:  2016-05       Impact factor: 1.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.